THE SENATE COMMITTEE ON
BUSINESS PROFESSIONS AND
ECONOMIC DEVELOPMENT WILL COME
TO ORDER. GOOD AFTERNOON,
EVERYONE. THANK YOU SO MUCH FOR
BEING HERE AS WE CONTINUE TO
TAKE SOME PRECAUTIONS TO MANAGE
ONGOING COVID RISKS. THE SENATE
CONTINUES TO WELCOME THE PUBLIC
AND HAS PROVIDED ACCESS TO BOTH
IN PERSON AND TELECONFERENCE
PARTICIPATION FOR PUBLIC COMMENT
FOR ALL INDIVIDUALS WISHING TO
PROVIDE PUBLIC COMMENT. THE
PARTICIPANT, TOLL FREE NUMBER
AND ACCESS CODE IS POSTED ON OUR
COMMITTEE WEBSITE AND I WILL
ANNOUNCE IT NOW. TODAY'S
PARTICIPANT NUMBER IS 844291.
AND THE ACCESS CODE IS 14111. I
WILL MAINTAIN DECORUM DURING
THIS HEARING, AS IS CUSTOMARY,
AND ANY INDIVIDUAL WHO IS
DISRUPTIVE MAY BE REMOVED FROM
THE REMOTE MEETING SERVICE. OR
HAVE THEIR CONNECTIONS MUTED. WE
ARE HOLDING TODAY'S COMMITTEE
HEARING IN OUR 12 10 21. OH
STREET LOCATION, ASK ALL MEMBERS
OF THE COMMITTEE TO BE PRESENT
IN ROOM 1200 SO THAT WE CAN
ESTABLISH A QUORUM. WE DO NOT
HAVE A QUORUM PRESENT, SO WE
WILL BEGIN AS A SUBCOMMITTEE,
SENATOR LAIRD, WELCOME. WE ARE
CONSIDERING SB 12 59. PLEASE
PROCEED WHEN YOU ARE READY.
THANK YOU, MADAM CHAIR AND
COMMITTEE MEMBERS AND THANK YOU
FOR MEETING SO SOON AFTER
SESSION. SB 12 59 ENSURES THAT
PHARMACISTS CAN DISTRIBUTE MORE
INNOVATIVE REVERSAL AGENTS
OTHERWISE KNOWN AS ANTAGONISTS,
WHICH WAS FASCINATING TO ME IS
TERMINOLOGY BECAUSE THE
ANTAGONISTS IS USUALLY PEOPLE.
WE DEAL WITH ANOTHER FORMS. UM
AND THESE ANTAGONISTS ARE FASTER
AND MORE EFFECTIVE TO REVERSE
OVERDOSE IN CASES INVOLVING
FENTANYL THAN WHAT HAS
TRADITIONALLY BEEN USED IN
RECENT YEARS. AH! OPIATES
OPIOIDS, MAINLY SYNTHETIC
OPIOIDS, INCLUDING FENTANYL, OR
CURRENTLY THE MAIN DRIVER OF
DRUG OVERDOSE DEATHS. PER THE
CENTERS FOR DISEASE CONTROL THE
RATES OF THESE DEATHS INVOLVING
SYNTHETIC OPIOIDS OTHER THAN
METHADONE, WHICH INCLUDES
FENTANYL AND FENTANYL, ANALOG
INCREASED OVER 56% JUST FROM
2019 TO 2020. TO HELP BATTLE THE
SURGE IN OVERDOSES OF FENTANYL,
A SYNTHETIC OPIOID THAT IS 50 TO
100 TIMES STRONGER THAN MORPHINE
. THE NATIONAL INSTITUTE OF
HEALTH CALLED FOR PUBLIC AND
PRIVATE INVESTMENTS TO DEVELOP
LONGER LASTING AND STRONGER
ASKING ACTING OPIOID ANTAGONISTS
, RESEARCHERS ARE DEVELOPING THE
NEXT GENERATION THAT WE USE
MOLECULES OTHER THAN NALOXONE,
THE MEDICINE THAT RAPIDLY
REVERSES AN OPIOID OVERDOSE BY
QUICKLY RESTORING NORMAL
BREATHING. THAT IS SLOW TO
STOPPED. THAT WILL LAST LONGER
AND ONLY REQUIRE ONE DOSE. SB 12
59 PROVIDES THE STATUTORY OF 40
NEEDED TO EQUIP PHARMACISTS WITH
THE ABILITY DISTRIBUTE THE MOST
APPROPRIATE. AN EFFECTIVE OPIOID
ANTAGONISTS IN THE PUBLIC RIGHT
NOW IT IS DRUG SPECIFIC. THIS
WOULD ALLOW IT AS NEW DRUGS ARE
DEVELOPED TO MAKE THOSE
AVAILABLE. THE BILL ENJOYS
BIPARTISAN SUPPORT. NO NO VOTES
. NO REGISTERED OPPOSITION. IT'S
SUPPORTED BY THE BOARD OF
PHARMACY BY THE CALIFORNIA
RETAIL ASSOCIATION AND THE
NATIONAL ASSOCIATION OF, UM. OF
DRUG STORE CHAINS. AND SO I
APPRECIATE YOUR TIME AND REQUEST
IN EITHER. THANK YOU, SENATOR
LAIRD. I DON'T HAVE ANY MAIN
WITNESSES, EVEN THOUGH I SUSPECT
THERE MIGHT BE SOME PEOPLE ON
THE PHONE BEFORE WE GET TO THAT.
WE'RE GOING TO ESTABLISH A
QUORUM. MADAM ASSISTANT, PLEASE
CALL THE ROLL LABOR HERE.
MELINDA'S ARCHULETTA HERE,
BATES. HEAR HEAR BECKER. DODD.
HERE HERE HERE, DODD EGGMAN.
HURTADO HERE TO HEAR JONES JONES
. HERE, MEN. NEWMAN JUST CALLED
YOUR NAME IN HERE IN HERE IN
HERE. NEWMAN CHOU BOGUE HERE.
THAT'S A GOOD SIGN PAN PRESENT
HERE HERE, ROTH. GREAT THANK YOU
VERY MUCH. A QUORUM HAS BEEN
ESTABLISHED. FIRST WE WILL MOVE
TO ANY SUPPORT HERE IN ROOM.
1200 PLEASE COME FORWARD. MADAM
CHAIR AND MEMBERS SYLVIA SALAS
SHAW HERE ON BEHALF OF THE CITY
OF SANTA MONICA. AND SUPPORT
THANK YOU VERY MUCH. ALRIGHT
LET'S GO TO THE PHONE LINES.
MODERATOR DO WE HAVE ANYONE WHO
WISHES TO EXPRESS THEIR SUPPORT
FOR S B? 12 59? THANK YOU TO
EXPRESS YOUR SUPPORT FOR SP 12
69, PLEASE PRESS ONE THROUGH IT
THIS TIME. WHAT A LINE 10! JUST
GO AHEAD. GOOD AFTERNOON. THIS
IS LINDSAY LOHAN WITH THE
CALIFORNIA RETAILERS ASSOCIATION
AND THE NATIONAL ASSOCIATION
ATTAINED DRUGSTORES AND SUPPORT.
THANK YOU. THANK YOU. ONE MOMENT
HERE WE HAVE ONE MORE.
FOR YOUR PATIENT HERE JUST A
MOMENT. NO PROBLEM.AND WILL
OPEN LINE NINE. PLEASE GO AHEAD.
HMM. MATTHEW WELSH WITH OPIUM
PHARMACEUTICALS, AND WE SUPPORT
THIS BILL, AND I'M ALSO
AVAILABLE FOR ANY FURTHER
QUESTIONS AS WELL. THANK YOU.
AND CURRENTLY NONE FURTHER IN. Q
TERRIFIC THANK YOU, MODERATOR.
ALRIGHT WELL, NOW GO TO
OPPOSITION. IS THERE ANYONE HERE
IN 1200 WHO WISHES TO OPPOSE
SEEING NO ONE. WE WILL GO TO THE
LINES. MADAM MODERATOR, IF YOU
COULD BRING ANYBODY ON THE LINE
WHO WISHES TO OPPOSE SB 12 59,
PLEASE. PLEASE PRESS 10 AT THIS
TIME. CURRENTLY NOBODY IN Q
GREAT THANK YOU VERY MUCH.
ALRIGHT, LET'S GO AHEAD AND
BRING IT BACK TO THE COMMITTEE.
SENATOR PAN, PLEASE PROCEED.
THANK YOU, MADAM CHAIR AND
CENTER. LAIRD FIRST OF ALL, I DO
APPRECIATE WHAT YOU'RE TRYING TO
ACCOMPLISH THE BILL. I DO HAVE
ONE CONCERN THAT I JUST WANT TO
RAISE. UM SO BASICALLY, WHAT
THIS BILL IS, IS THAT IT TAKES
THE CURRENT LAW, WHICH IS TALKS
ABOUT ONE SPECIFIC DRUG NALOXONE
, WHICH WE KNOW THE SAFETY
PROFILE AND SO FORTH. CHANGES TO
A CLASS OPIOID ANTAGONISTS. I
WANT TO THANK THE STAFF FOR THE
ANALYSIS, ALL THE EXISTING DRUGS
THAT KIND OF FIT IN THAT CLASS
CERTAINLY HAVE NO CONCERNS ABOUT
WE MAY NOT THERE MAY BE, YOU
KNOW. AGAIN TO TRY TO FUTURE
CAST RIGHT? THERE ARE OTHER
PROBABLY UNLIKELY THERE'S A
POSSIBILITY YOU COULD HAVE A
OPIOID ANTAGONISTS THAT MAY HAVE
A SAFETY PROFILE. WHERE SOMEONE
MAY QUESTION WHETHER IT BE
APPROPRIATE JUST TO HAVE IT
DISPENSED BY A PHARMACIST OR
SOMETHING IN THE FUTURE. SO UM,
WE DON'T KNOW, BUT I'LL BE THE
CIRCUMSTANCE OR NOT. SO I GUESS
LIKE THE SO CERTAINLY I WILL BE
SUPPORTING YOUR BILL. BUT I
THINK THE ONE THING I WOULD
PROBABLY THE CAVEAT I WOULD PUT
IN IS THAT I WOULD URGE THE
BOARD OF PHARMACY TO MONITOR
WHICH DRUGS ARE APPROVED UNDER
THIS CLASS, AND IF THERE'S ANY
CONCERNS OF THAT NATURE THAT
THEY SHOULD SHARE THAT WITH THE
LEGISLATURE IN CASE WE NEED TO
MAKE ANY SORT OF MODIFICATION OF
TO THE THIS DOES PASS AND BECOME
CODE THE CODE SO THEY ENSURE
THAT, UM, WE MAINTAIN THE SAFETY
OF THE PUBLIC AND THAT THE
OPIOID ANTAGONISTS THAT ARE
AVAILABLE TO BE DISPENSED. HAVE
THE KIND OF SAFETY PROFILE THAT
WE EXPECT THAT WE ARE
ANTICIPATING AS WE'RE VOTING ON
IT TODAY. SO WITH THAT,
CERTAINLY SUPPORTING YOUR BILL,
BUT I JUST WANT TO RATE THAT
CAVEAT. THANK YOU, MADAM CHAIR.
CAN I MAKE A COMMENT ON THAT?
YES THANK YOU. UM FIRST. I
APPRECIATE THAT, AND I THINK
THERE'S FDA APPROVAL AND IT IS A
LOW LIKELIHOOD BUT HAVING SAID
THAT I WOULD HAPPILY COMMIT TO
JOINING WITH YOU THAT IF THIS
BILL IS PASSED AND SIGNED INTO
LAW ABOUT JOINTLY WRITING A
LETTER TO THE BOARD OF PHARMACY
EXPRESSING THIS CONCERN, SO THEY
MAKE SURE THAT THEY MONITOR IT
GOING FORWARD. THANK YOU. THANK
YOU, SENATOR LAIRD. AND I
APPRECIATE THAT, AND I'D MAKE
NOTE THAT WHEN FDA APPROVED THE
DRUG WE HAVE MANY. IN FACT,
APPOINT THEMSELVES ARE FDA
APPROVED SO THEY CAN HAVE S
DIFFERENCE TO KIND OF SAFETY
PROFILES. BUT THANK YOU SO MUCH,
SENATOR LARRY AND I LOOK FORWARD
TO WORKING WITH YOU. THANK YOU.
THANK YOU, SENATOR. PAN MEMBERS
FURTHER QUESTIONS, COMMENTS OR
CONCERNS? YES SENATOR CHILE TO
THANK YOU, MADAM. SURE, SENATOR
, GREAT BILL, AND I THINK IT'S
THE MORE THE PUBLIC KNOWS ABOUT
THE HAZARDS BUT OPIOIDS AND SO
ON. MY QUESTION TO YOU IS, WILL
THERE BE ANY PUBLICATIONS? ANY
MATERIAL THAT THE PHARMACISTS
CAN GIVE TO THE GENERAL PUBLIC
TO BRING FURTHER AWARENESS AND I
KNOW THAT THE PHARMACISTS ARE
TAKING ADDITIONAL TRAINING TIME.
BUT IF THE GENERAL PUBLIC VISIT
, UNDERSTAND THE HAZARDS, THE
DANGER AND OVERDOSING AND SO ON
, SO MAYBE THE ASSOCIATION CAN
PUT TOGETHER A PR PROGRAM
SOMETHING TO GIVE TO THE GENERAL
PUBLIC. I HOPE YOU WOULD MIGHT
LOOK INTO THAT. WHAT DO YOU
THINK I WOULD HAPPILY LOOK INTO
IT, AND THE THING ABOUT IT IS
THERE IS GREAT. OUTREACH. ON THE
HAZARD OF THE DRUG. UH UM. BUT
THE QUESTION IS WHETHER THE
OUTREACH APPROPRIATELY TO THE
RESPONSE AND I THINK THAT'S WHAT
WE WOULD HAVE TO MAKE SURE THAT
WE WORKED ON AND THE PHARMACISTS
ARE REALLY IN SUPPORT OF THIS AS
A PARTICULARLY THE BOARD OF
PHARMACY AND SOME OF THE
RETAILERS. AND SO I THINK WE'RE
IN A POSITION TO WORK. WITH
THEM. TO MAKE SURE THAT THERE'S
OUTREACH SO THAT PEOPLE KNOW
BECAUSE IT'S NOT USEFUL AND
PEOPLE KNOW SURE IN THAT LIGHT,
OF COURSE IN THE SPANISH
SPEAKING WORLD AND OTHER
LANGUAGES, IF THEY CAN CREATE
THESE PAMPHLETS WOULD REALLY
HELP AND IT'S NOT JUST GEARED
ONE. BUT IT GOES ACROSS THE
SPECTRUM OF ALL LANGUAGES AND SO
ON, SO WE NEED TO GET THE
GENERAL PUBLIC INVOLVED TO
REALIZE THAT IF THEY'RE GOING TO
PARTICIPATE, YOU KNOW, LET'S
SHARE THE KNOWLEDGE. TO THEIR
FAMILIES, AND SO ON IN THE
DANGERS I LIKE THAT, AND SENATOR
BATES SPEAKS SPANISH, AND SHE'S
GONNA HAVE A LOT OF TIME ON HER
HANDS. SO MAYBE WE CAN RECRUIT
HER TO HELP WITH THAT OUT. THERE
YOU GO. THANK YOU, SENATOR.
MADAM CHAIR, SENATOR JONES.
THANK YOU, MA'AM. SURE. I THINK
SENATOR BATES IS GOING TO BE
BUSY BEING A SUPERVISOR IN
ORANGE COUNTY. BUT WITH THAT
I'LL MOVE THE BILL FOR APPROVAL.
THANK YOU. THANK YOU VERY MUCH.
OTHER QUESTIONS, COMMENTS
CONCERNS. SEEING AND HEARING
NONE. SENATOR LAIRD. WOULD YOU
LIKE TO CLOSE? I APPRECIATE THE
DISCUSSION, AND I RESPECTFULLY
ASK FOR AN IPHONE. THANK YOU,
SIR. THE BILL HAS BEEN MOVED BY
SENATOR JONES, MAN CONSULTANT.
PLEASE CALL THE ROLL. 12 59
MOTION IS THAT THE ASSEMBLY
AMENDMENTS BE CONCURRED IN LIBYA
, MELINDA'S ARCHULETTA, TÔI
BATES BECKER. RIGHT, I DODD.
EDMUND EDMUND. I HEARD POTATO I
JONES. JONES I'M A NÓI NEWMAN
BIOKO BUG PAN. VERY GOOD. THAT
BILL HAS 11 VOTES AND WE'RE
GONNA GO AHEAD AND CALL IT 11
EYES AND NO KNOWS THAT BILL IS
OUT. THANK YOU MEMBERS VERY MUCH
FOR BEING HERE PROMPTLY AND
THANK YOU. EVERYONE WHO CAME OR
CALLED IN IF YOUR COMMENTS WERE
NOT HEARD, PLEASE FEEL FREE TO
SEND THEM TO THE COMMITTEE AND
THE COMMITTEE ON BUSINESS,
ECONOMIC DEVELOPMENT IS
ADJOURNED. ALRIGHT. GREAT JOB,
EVERYONE.